Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Change in Receivables (2016 - 2026)

Dexcom has reported Change in Receivables over the past 17 years, most recently at -$124.6 million for Q1 2026.

  • Quarterly Change in Receivables fell 183.68% to -$124.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$71.6 million through Mar 2026, down 140.2% year-over-year, with the annual reading at $201.9 million for FY2025, 476.86% up from the prior year.
  • Change in Receivables was -$124.6 million for Q1 2026 at Dexcom, down from $106.2 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $187.2 million in Q4 2023 and troughed at -$237.8 million in Q3 2025.
  • The 5-year median for Change in Receivables is $30.1 million (2022), against an average of $33.7 million.
  • The largest YoY upside for Change in Receivables was 2467.24% in 2025 against a maximum downside of 527.7% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $148.3 million in 2022, then grew by 26.23% to $187.2 million in 2023, then plummeted by 96.05% to $7.4 million in 2024, then soared by 1335.14% to $106.2 million in 2025, then plummeted by 217.33% to -$124.6 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Change in Receivables are -$124.6 million (Q1 2026), $106.2 million (Q4 2025), and -$237.8 million (Q3 2025).